# Madeira Therapeutics, LLC: Form D filings

Madeira Therapeutics, LLC, a pharmaceuticals company in Leawood, KS, filed 2 Form D notices with the SEC between 2010 and 2011. The latest, on April 13, 2011, reports $420,000 sold of a $2 million offering to 3 investors.

Find out what Madeira Therapeutics, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Madeira%20Therapeutics%2C%20LLC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Madeira%20Therapeutics%2C%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Fmadeira-therapeutics-llc-1482275)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Madeira%20Therapeutics%2C%20LLC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Madeira%20Therapeutics%2C%20LLC&page=%2Fdata%2Fform-d%2Fcompany%2Fmadeira-therapeutics-llc-1482275)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Kansas](https://specstream.ai/data/form-d/state/kansas): 193 rows, by operating companies, filed since November 1, 2024, $9.65, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/kansas
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 4745 W. 136TH STREET, SUITE 102, Leawood, KS, 66224
- Phone: (913) 661-1962
- Industry: Pharmaceuticals
- Entity type: Limited Liability Company
- Incorporated in: Kansas
- Year incorporated: 2007
- Revenue range: No Revenues
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1482275

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Apr 13, 2011 | Amendment | $2,025,000 | $420,000 | $1,605,000 | 3 | Apr 1, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1482275/000148227511000001/0001482275-11-000001-index.htm) |
| Apr 13, 2010 | New notice | $2,025,000 | $90,000 | $1,935,000 | 1 | Apr 1, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1482275/000148227510000001/0001482275-10-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Craig L. Chance | Executive Officer |  |
| Peter R. Joiner | Executive Officer, Promoter |  |
| -- V. Camargo Pharmaceutical Services, LLC | Promoter |  |
| Kenneth V. Phelps | Executive Officer, Promoter |  |

[Every Form D from the week of Apr 11, 2011](https://specstream.ai/data/form-d/week/2011-04-11) · [All recent filings in Kansas](https://specstream.ai/data/form-d/state/kansas) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Madeira Therapeutics, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).